NFG
TARS icon

Nations Financial Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Nations Financial Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,000
Closed -$357K – 772
2025
Q3 		$357K Hold
6,000
– – 0.02% 562
2025
Q2 		$243K Hold
6,000
– – 0.02% 603
2025
Q1 		$308K Hold
6,000
– – 0.02% 528
2024
Q4 		$332K Buy
+6,000
New +$273K 0.02% 528
2024
Q2 		– Sell
-6,000
Closed -$218K – 657
2024
Q1 		$218K Buy
+6,000
New +$176K 0.02% 584

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Nations Financial Group's TARS Position: Q4 2025 in Review

Nations Financial Group sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 6,000 shares — an estimated $357K sold.

Nations Financial Group first reported a position in TARS in Q1 2024 and held it in 5 quarters. The position peaked at $357K in Q3 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • Nations Financial Group reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Nations Financial Group sold 6,000 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $357K.
  • Nations Financial Group first reported a position in Tarsus Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Nations Financial Group's Tarsus Pharmaceuticals position peaked at $357K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Nations Financial Group's 13F filing for Q4 2025, filed 26 Jan 2026.